Alkem Laboratories Ltd — Financial Report

• Market Cap: ₹53,671 Cr • Current Price: ₹4,468 • High / Low: ₹5,257 / ₹3,495 • Stock P/E: 38.2 • Book Value: ₹918 • Dividend Yield: 0.86% • ROCE: 21.2% • ROE: 16.3% • Face Value: ₹2.00 Financial Performance: • Revenue: ₹14,528 Cr • Net Profit: ₹1,403 Cr • Profit Growth: -10.1% YoY • EPS: ₹116.9 • Compounded Sales Growth: 5 Years – 12%, 3 Years – 10%, TTM – 14% • Compounded Profit Growth: 5 Years – 16%, 3 Years – 12%, TTM – -10% • Return on Equity: 5 Years – 16%, 3 Years – 17%, Last Year – 16% Shareholding Pattern: • Promoters: 57.2% • FIIs: 3.65% • DIIs: 21.2% • Public: 17.95% Key Insights: • Consistent ROE above 16% over the past five years. • Revenue growth is steady, but profit declined in the last year due to cost pressures. • Low debt and strong balance sheet position. • Attractive dividend yield for a pharma growth company. • Stock trades at a premium P/E due to strong brand and domestic market leadership.